"Merck's third-quarter profit plunged to $1.09 billion"
But they still MADE over a BILLION in the QUARTER?
"Wyeth reported a slight drop in its third-quarter profit as profit fell to $1.14 billion"
But they still MADE over a BILLION in the QUARTER?
"GlaxoSmithKline... posted better-than-expected results... profit dipped to $2.1 billion"
They made OVER TWO BILLION?
Sigh. Sick of the FUCKING WORD GAMES yet, readers?
How did you do this year, Amurka? Did YOUR PROFITS PLUNGE to ONE BILLION this QUARTER? Did YOU get a BILLION-DOLLAR BAILOUT?
"Major drug makers' sales suffer in the third quarter" by Associated Press | October 23, 2008
TRENTON, N.J. - Drug makers Merck & Co., Wyeth, and GlaxoSmithKline PLC all posted lower profits for the third quarter yesterday, partly due to the intensifying generic competition weighing on the entire pharmaceutical industry.
And in what it characterized as an advance strike to counteract that and other problems, Merck said it will slash about 7,200 jobs, or nearly 13 percent of its workforce, in its second major restructuring in less than three years.
Merck, which currently has 250 employees at its research center in Boston's Longwood Medical Area, plans to expand its Massachusetts operations as part of the restructuring. Spokesman Ian McConnell said the company is shifting its molecular profiling group from Seattle to Boston by 2009. Merck is also shifting its basic research for the oncology and Bone Respiratory Immunology and Endocrine groups to Boston by year's end. McConnell said the company, which already has partnerships with many Bay State institutions, such as Harvard University and Vertex Pharmaceuticals Inc., also hopes to forge more partnerships with outside groups.
Seattle's loss is OUR GAIN (inject knife into northwest Americans back)!!!!
Merck, Wyeth, and GlaxoSmithKline managed to meet or slightly beat analysts' expectations, in part because of benefits from currency exchange rates.
?????????
Merck's third-quarter profit plunged to $1.09 billion.
Wyeth reported a slight drop in its third-quarter profit as profit fell to $1.14 billion.
GlaxoSmithKline, the world's second-largest drug maker, posted better-than-expected results as the weak British pound boosted revenue. Net profit dipped to $2.1 billion. --more--"Yeah, I do get angry, curse, and swear because of this kind of BULLSHIT REPORTING!!
